LAS
VEGAS, June 18, 2024 /PRNewswire/
-- SeeMedX, Inc. ("SeeMedX") today announced the appointment
of Dr. Peter Ganz to its advisory
board, effective immediately. Dr. Ganz is a distinguished leader in
cardiology and a pioneer in clinical cardiac research, including
current work with precision medicine enabled by proteomics and
machine learning.
"Dr. Ganz's extensive expertise and experience will be
instrumental in guiding SeeMedX as we advance our innovative
cardiac monitoring solutions," said SeeMedX CEO, Deborah Simpson. "Because of his standing in the
cardiology community, his belief in the efficacy of SeeMedX's
non-invasive hemodynamic monitoring system will be influential with
cardiologists around the world."
Dr. Ganz is Director of the Center of Excellence in Vascular
Research at the Zuckerberg San Francisco General Hospital and is
also a Professor of Medicine at the University
of California, San Francisco ("UCSF"). Previously he served
as the Chief of the Cardiovascular Division at Zuckerberg San
Francisco General Hospital and the Maurice Eliaser Distinguished
Professor of Medicine at UCSF from 2008 to 2019. Prior to that
time, Dr. Ganz spent 25 years directing cardiovascular research in
the Cardiac Catheterization Laboratories at the Brigham and Women's
Hospital and Harvard Medical School.
Dr. Ganz has published extensively in prestigious medical journals
and has received numerous recognitions for his contributions to
cardiology.
"In today's environment, doctors need access to technology like
SeeMedX has developed," said Dr. Ganz. "Their non-invasive
hemodynamic monitor can provide much needed information accurately,
economically, safely, and rapidly. It has the potential to prevent
hospitalizations for acute decompensated heart failure by
diagnosing volume overload before it becomes clinically apparent. I
look forward to working with them to establish the use of the
technology as a clinical standard in cardiology practices."
About SeeMedX
SeeMedX is dedicated to revolutionizing
cardiac care through the development of advanced cardiac monitoring
systems utilizing bioimpedance technology. Our mission is to
provide healthcare professionals with accurate, real-time data to
improve patient outcomes. For more information,
visit www.seemedx.com.
For more information:
Visit www.seemedx.com
Follow us on LinkedIn
View original content to download
multimedia:https://www.prnewswire.com/news-releases/seemedx-announces-appointment-of-dr-peter-ganz-to-advisory-board-302175995.html
SOURCE SeeMedX, Inc.